Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation

Fig. 2

The proportion of CD4+Foxp3−CCR8+/CD4+Foxp3+CCR8+ cells, CD4+CCR8−/CD4+CCR8+ Tregs and the mean fluorescence intensity of CCR8 on HC-PBL, OC-PBL and OC-TIL groups A Representative flow cytometry analysis of CD4+Foxp3−CCR8+/CD4+Foxp3+CCR8+ cells in HC-PBL group (Foxp3 was used for gating CD4+CCR8+ cells). B Representative flow cytometry analysis of CD4+Foxp3−CCR8+/CD4+Foxp3+CCR8+ cells in OC-PBL group (Foxp3 was used for gating CD4+CCR8+ cells). C Representative flow cytometry analysis of CD4+Foxp3−CCR8+/CD4+Foxp3+CCR8+ cells in OC-TIL group (Foxp3 was used for gating CD45+CD3+CD4+CCR8+ cells). D Statistical chart of the percentage of CD4+Foxp3−CCR8+/CD4+Foxp3+CCR8+ cells in HC-PBL (n = 16), OC-PBL (n = 16) and OC-TIL (n = 16) groups. E Representative flow cytometry analysis of CD4+CCR8−/CD4+CCR8+ Tregs in HC-PBL group (CCR8 was used for gating CD4+Foxp3+ cells). F Representative flow cytometry analysis of CD4+CCR8−/CD4+CCR8+ Tregs in OC-PBL group (CCR8 was used for gating CD4+Foxp3+ cells). G Representative flow cytometry analysis of CD4+CCR8−/CD4+CCR8+ Tregs in OC-TIL group (CCR8 was used for gating CD45+CD3+CD4+Foxp3+ cells). H Statistical chart of the proportion of CD4+CCR8−/CD4+CCR8+ Tregs in HC-PBL (n = 22), OC-PBL (n = 16) and OC-TIL (n = 13) groups. I Statistical chart of the proportion of CD4+CCR8 + Tregs in HC-PBL (n = 22), OC-PBL (n = 16) and OC-TIL (n = 13) groups. J Statistical chart of the mean fluorescence intensity (MFI) of CCR8 on HC-PBL (n = 22), OC-PBL (n = 16) and OC-TIL (n = 13) groups. Data are presented as means ± SD and analysed with Student’s t-test. (**P < 0.01; ***P < 0.001; ****P < 0.0001)

Back to article page